Detalhe da pesquisa
1.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604296
2.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol
; 22(4): 789-797.e8, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048934
3.
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Hepatology
; 78(1): 195-211, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924031
4.
Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction-associated steatotic liver disease.
Liver Int
; 44(5): 1167-1175, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353063
5.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver Int
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573034
6.
Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis.
Expert Opin Emerg Drugs
; : 1-11, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469871
7.
Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.
BMC Gastroenterol
; 24(1): 57, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302914
8.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661715
9.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
JAMA
; 331(15): 1287-1297, 2024 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512249
10.
Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.
Clin Gastroenterol Hepatol
; 21(2): 380-387.e3, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123096
11.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Clin Gastroenterol Hepatol
; 21(2): 370-379, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051649
12.
A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
Am J Gastroenterol
; 118(5): 840-847, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305695
13.
Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Hepatology
; 75(3): 661-672, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496054
14.
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology
; 76(1): 186-195, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34951726
15.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int
; 43(10): 2210-2219, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470077
16.
Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease.
Hepatol Res
; 53(3): 219-227, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378589
17.
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease.
Hepatol Res
; 53(10): 978-988, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353881
18.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res
; 53(4): 312-321, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524984
19.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(6): 489-496, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807720
20.
M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis.
Hepatol Res
; 53(9): 844-856, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237426